SCHEMBL31577393

SCHEMBL31577393

CNc1nc(Nc2ccc(=O)n(C(F)F)c2)c(C(=O)OC)nc1-c1nc2ccncc2n1C

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ AOC3 Q16853 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29173495 0.79 — —
SCHEMBL30205931 0.79 — —
SCHEMBL31577281 0.77 RPS6KA5 (0.41) TP53POLB
SCHEMBL31577339 0.76 BMI1 (0.37) POLB
SCHEMBL31577303 0.75 JAK2 (0.32) TP53
SCHEMBL31577344 0.75 BRD4 (0.30) —
SCHEMBL31577350 0.71 AOC3 (0.37) AOC3
SCHEMBL31577284 0.70 LRRK2 (0.41) AOC3
SCHEMBL31577293 0.69 RPS6KA5 (0.41) TP53POLB
SCHEMBL31577359 0.68 BUB1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373817-B1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2025-05-21 — — EP disclosed
Send feedback